24.10.2025

Alithea Bio to Participate at BIO-Europe 2025

Alithea Bio Bio Europe

We’re thrilled to announce that Alithea Bio will join BIO-Europe 2025, taking place November 3–5, 2025 at the Vienna Congress and Convention Center, Austria, followed by digital partnering sessions on November 11–12.
BIO-Europe is one of the most influential life sciences events, uniting global biotech, pharma, and investment leaders. It’s where partnering becomes the science of connection — designed to make every meeting purposeful, every collaboration meaningful, and every innovation one step closer to reality.
Representing Alithea Bio at the event will be Dr. Armanas Povilionis and Dr. Mirjam van Bentum, who will be available to connect with fellow biotech professionals, discuss collaborations, and explore how our technologies can support innovation across the life sciences sector.
At Alithea Bio, we are dedicated to transforming the landscape of biopharmaceutical research through AI-driven proteogenomic analytics and advanced immunopeptidomics. Our platform, HLA-Compass, enables scientists to identify novel therapeutic targets and evaluate off-target risks with precision.
Join  Dr. Armanas Povilionis and Dr. Mirjam van Bentum at BIO-Europe 2025 to explore how Alithea Bio can help accelerate your R&D and foster impactful partnerships in biotechnology and life sciences.

:date: Event: BIO-Europe 2025
 :round_pushpin: Location: Vienna Congress and Convention Center, Vienna, Austria
 :spiral_calendar_pad: Date: November 3–5, 2025
 :computer: Digital Partnering: November 11–12, 2025
We look forward to connecting with innovators and leaders driving the future of biotech!

Read more

7th-TCR-Based-Therapies-Summit-logo-1-scaled-1.webp Aliteha bio

Alithea Bio to Join Industry Leaders at the 7th TCR-Based Therapies Summit in Boston

Read
Alisa Fuchs, PhD, German Innovation Award 2026

Alithea Bio Receives German Innovation Award 2026 for HLA-Compass Platform

Read
HLA binding prediction tool HLA-Compass AI Alithea Bio deep learning immunopeptidomics

HLA Binding Prediction: How Alithea Bio Outperforms MHCflurry 2.0

Read